[Sandra Gamber]

A registrar in the field just reported this as well using their state 16B metafile. I tested it by using just the NAACCR16B metafile as well & received the same edit (see below).

Metafile Name: NAACCR_v16B_20161005.rmf
EditSets Used: Hosp: Vs16 COC Required – All + CS

Edit Name: Mets at DX-BBDLLO, HemeRetic (SEER)
Edit Set Name: Hosp: Vs16 COC Required – All + CS
Edit Error Message: Mets at DX fields are invalid for site/hist combination.
Field(Pos): Primary Site (540)=> C421
Field(Pos): Histologic Type ICD-O-3 (550)=> 9811
Field(Pos): Behavior Code ICD-O-3 (554)=> 3
Field(Pos): Mets at DX-Bone (838)=> 8
Field(Pos): Mets at DX-Brain (839)=> 8
Field(Pos): Mets at Dx-Distant LN (840)=> 8
Field(Pos): Mets at DX-Liver (841)=> 8
Field(Pos): Mets at DX-Lung (842)=> 8
Field(Pos): Mets at DX-Other (843)=> 8
Field(Pos): Date of Diagnosis (530)=> Y:2016 M:05 D:31
Field(Pos): Type of Reporting Source (563)=> 1

The Hematopoietic, Reticuloendothelial, Immunoproliferative, and Myeloproliferative Neoplasms are identified within the edit logic as follows: This particular case qualifies for Heme4.
Heme4 – Neoplasms accepted as either leukemia or lymphoma: Histologic Type ICD-O-3 9811-9818, 9837 with Primary Site C420, C421, C424. NOTE: Any valid code for a Mets at DX field will be accepted for this group of sites/histologies.

[Author]

Posts